Quote | Indaptus Therapeutics Inc. (NASDAQ:INDP)
Last: | $2.07 |
---|---|
Change Percent: | -0.0% |
Open: | $2.0501 |
Close: | $2.07 |
High: | $2.09 |
Low: | $2.0501 |
Volume: | 5,623 |
Last Trade Date Time: | 05/08/2024 03:00:00 am |
News | Indaptus Therapeutics Inc. (NASDAQ:INDP)
2024-05-08 10:29:35 ET More on Indaptus Therapeutics Seeking Alpha’s Quant Rating on Indaptus Therapeutics Historical earnings data for Indaptus Therapeutics Financial information for Indaptus Therapeutics Read the full article on Seeking Alpha ...
NEW YORK, May 08, 2024 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus” or the “Company”), a clinical stage biotechnology company dedicated to pioneering innovative cancer and viral infection treatments, today announced financial results for t...
Message Board Posts | Indaptus Therapeutics Inc. (NASDAQ:INDP)
Subject | By | Source | When |
---|---|---|---|
$INDP MomentumIts gaining | Surfacetite | investorshub | 05/08/2023 8:37:38 AM |
$INDP got some short data | DeadCellShadix | investorshub | 05/08/2023 1:32:26 AM |
Price gaining | Surfacetite | investorshub | 05/07/2023 3:23:16 PM |
$INDP MomentumIts now last trade up | MonstaGains | investorshub | 05/03/2023 4:25:58 PM |
The gaining up | MonstaGains | investorshub | 05/01/2023 7:51:29 PM |
News, Short Squeeze, Breakout and More Instantly...
Indaptus Therapeutics Inc. Company Name:
INDP Stock Symbol:
NASDAQ Market:
NEW YORK, May 08, 2024 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus” or the “Company”), a clinical stage biotechnology company dedicated to pioneering innovative cancer and viral infection treatments, today announced financial results for t...
NEW YORK, April 11, 2024 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc, (Nasdaq: INDP), a clinical stage biotechnology company dedicated to pioneering innovative cancer and viral infection treatments, was proud to unveil its poster at the 2024 Annual Meeting of the American Association for Cance...
NEW YORK, March 28, 2024 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (NASDAQ:INDP), a clinical stage biotechnology company dedicated to pion...